Who invested in Braizon Therapeutics?
Braizon Therapeutics's investors include SMBC Venture Capital and UTokyo Innovation Platform.
Japan · Series B startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$9.5Mraised across 1 round since 2021, from 1 source
Braizon Therapeutics's investors include SMBC Venture Capital and UTokyo Innovation Platform.
Braizon Therapeutics has raised $9.5M across 1 round since 2021.
Braizon Therapeutics's most recent round was a Series B of $9.5M in Jul 2021.
Its most recent round, $9.5M in Jul 2021, is also its largest on record.
Braizon Therapeutics's first round on record, in Jul 2021, was backed by SMBC Venture Capital and UTokyo Innovation Platform.
Braizon Therapeutics's latest named round is a Series B, in Jul 2021.
Braizon Therapeutics is based in Japan.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.